<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Sirtris Exec Says Acquisition by GlaxoSmithKline is &#8220;Great for Boston&#8221;</title>
	<atom:link href="http://www.xconomy.com/boston/2008/04/22/sirtris-exec-says-acquisition-by-glaxosmithkline-is-great-for-boston/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/boston/2008/04/22/sirtris-exec-says-acquisition-by-glaxosmithkline-is-great-for-boston/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sat, 21 Nov 2009 22:30:41 -0600</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.6</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Dr. James Harding</title>
		<link>http://www.xconomy.com/boston/2008/04/22/sirtris-exec-says-acquisition-by-glaxosmithkline-is-great-for-boston/comment-page-1/#comment-14051</link>
		<dc:creator>Dr. James Harding</dc:creator>
		<pubDate>Tue, 22 Apr 2008 23:40:59 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/2008/04/22/sirtris-exec-says-acquisition-by-glaxosmithkline-is-great-for-boston/#comment-14051</guid>
		<description>As I see it the dilemma for Sirtris, and now Glaxo, is that the products they are developing already exist in effective natural, inexpensive form. Given, his synthetic analogs may be more potent or targeted against specific conditions such; however biotivia transmax, the natural form of concentrated resveratrol, is available now and has been shown in peer reviewed studies to be safe and effective. Synthetic analogs historically have been shown to be somewhat unpredictable in effect and safety. Why not simply stick with the natural form? It is here now and does not require an expensive physician&#039;s appointment.  To succeed Glaxo will have to come up with sythetic versions of resveratrol that are shown to be clearly superior to resveratrol itself and just as safe.</description>
		<content:encoded><![CDATA[<p>As I see it the dilemma for Sirtris, and now Glaxo, is that the products they are developing already exist in effective natural, inexpensive form. Given, his synthetic analogs may be more potent or targeted against specific conditions such; however biotivia transmax, the natural form of concentrated resveratrol, is available now and has been shown in peer reviewed studies to be safe and effective. Synthetic analogs historically have been shown to be somewhat unpredictable in effect and safety. Why not simply stick with the natural form? It is here now and does not require an expensive physician&#8217;s appointment.  To succeed Glaxo will have to come up with sythetic versions of resveratrol that are shown to be clearly superior to resveratrol itself and just as safe.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
